Pharma Inc agrees to cap margins on non-price control drugs at 30%
Big pharma companies with generic divisions — such as Sun Pharma, Cipla and Lupin — will have to reduce MRP. Source: Pharma Inc agrees to cap margins on non-price control drugs at 30%
Pharma wrap: NPPA drug price hike and the need for robust price regulation of medicines
NPPA said it considered the view that unviability of these formulations should not lead to a situation where these drugs become unavailable in the market and that the public is forced to switch to costly alternatives
Pharma Inc agrees to cap margins on non-price control drugs at 30%
Big pharma companies with generic divisions — such as Sun Pharma, Cipla and Lupin — will have to reduce MRP. Source: Pharma Inc agrees to cap margins on non-price control drugs at 30%
